![]() |
confused about Fish results
I just got a copy of my biopsy FISH report today and am confused about what it said. I looked at the resources available on evaluating the report but am still confused. Maybe some of you all can help a little. Here is what I don't understand
Her-2/neu: CEF-17 ratio: 7,8:1 Average her-2/neu count per cell 15.6 Mamimum her-2/neu count per cell 22 Average CEP-17 count per cell: 2.0 Cells counted: 25 This resulted in a Positive/ Amplified Interpertation which is explained as Results> 2.2 with an average Her-2 signal count of 4>copies/cell, and [referably >7 copies/cell in a majority of scored nuclei. In all these numbers does it relate to my Ki-67? |
anyone have ideas, was I not clear about what I was asking? I know I can ask my doc, but you all are like jello, fast, friendly and usually fail proof.
|
Laurie, Believe me...someone here will have an answer for you. Possible Becky or a few others I can think of. They are probably just busy at the moment...but when they check in I am sure you will get a few replies.
Hang in there...help is on the way. http://www.her2support.org/vbulletin...lies/smile.gif Chelee |
Her-2/neu: CEF-17 ratio: 7,8:1
Average her-2/neu count per cell 15.6 Mamimum her-2/neu count per cell 22 Average CEP-17 count per cell: 2.0 Cells counted: 25 The way I read it... they evaluated 25 cancer cells. The average HER-2/neu count was 15.6 per cell. Divide your average HER-2 by the average CEP-17 gives you the ratio. 15.6/2.0 is 7.8. So your ratio is 7.8:1. Anything over 2 is an overexpression of HER-2. (The max HER-2 they saw on any one cell was 22.) I do not know the relationship between this and the Ki-67 score. Skeetur |
http://www.nccn.org/patients/fact_sheet.asp
Try this website. I think it might answer your questions. |
Ki67 is an entirely different marker
It is considered a marker of proliferation...so even within tumors with her2 amplification there are those which multiply faster than others.
Hope this helps! |
| All times are GMT -7. The time now is 02:46 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021